Verano Holdings's EBIT per Share for the
three
months ended in Mar. 2026 was $0.08.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.74.
During the past 12 months, the average EBIT per Share Growth Rate of Verano Holdings was -13.90% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 2.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 18.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Verano Holdings's EBIT per Share or its related term are showing as below:
VRNOD'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 2.2 Med: 11.7 Max: 65
Current: 2.2
During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Verano Holdings was 65.00% per year. The lowest was 2.20% per year. And the median was 11.70% per year.
VRNOD's 3-Year EBIT Growth Rate is ranked worse than 59.65% of 808
companies
in the Drug Manufacturers industry
Industry Median: 7.6
vs VRNOD: 2.20
Verano Holdings's EBIT for the
three
months ended in Mar. 2026 was $6.1 Mil.
Verano Holdings (OTCPK:VRNOD) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Verano Holdings EBIT per Share Related Terms
Verano Holdings EBIT per Share Historical Data
* Premium members only.
The historical data trend for Verano Holdings's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.74
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Verano Holdings (VRNOD) has a EBIT per Share of $-1.74 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Verano Holdings and its competitors. According to the industry distribution chart, Verano Holdings ranks #482 out of 808 companies in the Drug Manufacturers industry, placing it in the top 59.7%.
Is Verano Holdings' EBIT per Share too high?
Verano Holdings' current EBIT per Share is $-1.74. Based on the distribution chart, Verano Holdings ranks #482 out of 808 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Verano Holdings has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Verano Holdings' EBIT per Share compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Verano Holdings ranks #482 out of 808 companies for EBIT per Share. This places Verano Holdings in the lower half of its industry. The industry median EBIT per Share is 7.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.60, based on 808 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Verano Holdings and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Verano Holdings's current EBIT per Share is $-1.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Verano Holdings stock overvalued right now?
Based on GuruFocus' analysis, Verano Holdings (VRNOD) is currently considered Possible Value Trap. The stock's GF Value™ is $7.76, compared to a current price of $5.31 — trading 31.6% below its estimated fair value. The current EBIT per Share is $-1.74. Verano Holdings' overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Verano Holdings (VRNOD), the current EBIT per Share is $-1.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Verano Holdings (VRNOD) Overvalued in 2026?
Based on GuruFocus' analysis, Verano Holdings stock appears to be undervalued.
The current stock price of $5.31 is trading 31.6% below its estimated GF Value™ of $7.76.
GuruFocus considers Verano Holdings to be Possible Value Trap.
Key valuation signals for VRNOD:
EBIT per Share: $-1.74
GF Value™: $7.76 vs. price of $5.31 (31.6% below fair value)
No single metric tells the full story. See the VRNOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Verano Holdings Corp is a vertically integrated, multi-state cannabis operator in the United States. The company operates through cultivation (wholesale) and retail segments. Its consumer brands include Encore, Avexia, MUV, Savvy, BITS, and Verano, while its retail dispensaries operate under brands such as Zen Leaf and MUV. The company derives the majority of its revenue from the retail segment.
65GF Score
Get the complete analysis for VRNOD
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VRNOD has been successfully added to your 
